GB769757A - Improvements in or relating to the manufacture of sulfonamides - Google Patents
Improvements in or relating to the manufacture of sulfonamidesInfo
- Publication number
- GB769757A GB769757A GB13636/55A GB1363655A GB769757A GB 769757 A GB769757 A GB 769757A GB 13636/55 A GB13636/55 A GB 13636/55A GB 1363655 A GB1363655 A GB 1363655A GB 769757 A GB769757 A GB 769757A
- Authority
- GB
- United Kingdom
- Prior art keywords
- radical
- thiadiazole
- anhydride
- sulphonamide
- propionyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Abstract
2 - Acylamino - 1,3,4 - thiadiazole - 5 - sulphonamides of the general formula <FORM:0769757/IV(b)/1> wherein R1 is an acyl radical and R2 is then hydrogen, and when R1 and R2 are taken together they form the phthaloyl radical, are prepared by reacting 2-amino-1,3,4-thiadiazole-5-sulphonamide with the required carboxylic acid anhydride or acyl chloride. In the case of the anhydride reactants, the process may be carried out in the absence of solvents, a suitable reaction temperature using an anhydride reactant being 100 DEG to 200 DEG C., preferably 140 DEG to 180 DEG C. In the case of the acyl chloride reactants, the process is preferably carried out in the presence of an acid acceptor, e.g. pyridine, quinoline, triethylamine, tripropylamine or other tertiary aliphatic amine, or an inorganic base such as an alkali metal hydroxide, carbonate or bicarbonate. The group R1 may be a lower alkyl carbonyl radical such as a propionyl, acetyl, trifluoroacetyl, butyryl, isobutytyl, chloroacetyl, aminoacetyl, valeryl, or isovaleryl radical, or an aroyl radical such as the benzoyl radical. In the examples, the following compounds are prepared: 2-propionyl-, 2-acetylamino-, 2-trifluoroacetylamino-, 2-phthaloylamino-, 2-n-butyrylamino-, 2-chloroacetylamino-, 2-isovalerylamino-, 2-benzoylamino-, 2-isobutyrylamino-, and 2-[(N-carbobenzoxy) glycylamino] - 1,3,4 - thiadiazole - 5 - sulphonamide. Specification 687,760 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US769757XA | 1954-05-13 | 1954-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB769757A true GB769757A (en) | 1957-03-13 |
Family
ID=22135372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB13636/55A Expired GB769757A (en) | 1954-05-13 | 1955-05-11 | Improvements in or relating to the manufacture of sulfonamides |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB769757A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
CN111646954A (en) * | 2020-07-22 | 2020-09-11 | 双鹤药业(商丘)有限责任公司 | Novel acetazolamide crystal form and preparation method thereof |
-
1955
- 1955-05-11 GB GB13636/55A patent/GB769757A/en not_active Expired
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
CN111646954A (en) * | 2020-07-22 | 2020-09-11 | 双鹤药业(商丘)有限责任公司 | Novel acetazolamide crystal form and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB769757A (en) | Improvements in or relating to the manufacture of sulfonamides | |
DE3264656D1 (en) | Process for the production of a peroxy compound | |
GB1113618A (en) | 3-hydroxyisoazole derivatives | |
GB1123929A (en) | Unsaturated sulphonic acid betaines and a process for their production | |
US3435048A (en) | Process for preparing 5-aryl-3-aminoisoxazoles | |
GB952477A (en) | Improved process for obtaining ª-ª, ª-ª unsaturated carboxylic esters | |
US2806036A (en) | Process for preparation of | |
GB959420A (en) | Oxyalkylated carboxylic acid amides and production thereof | |
US2477869A (en) | Nitro sulfonates from beta-nitro alkanols | |
SU632302A3 (en) | Method of producing 1,3,4-thiadiazole-2-ylureas | |
US2921960A (en) | Substituted amino-carboxylic acid amides and method of making the same | |
GB1085038A (en) | Process for the manufacture of n-acyl taurides | |
GB787061A (en) | Process for producing n-methyl--a-phenylsuccinimide | |
GB808304A (en) | Thiophosphoric acid esters and their preparation | |
GB795458A (en) | Derivatives of ª-amino-ª-hydroxy-acids and the manufacture thereof | |
GB798846A (en) | N-picolinoyl-phthalic acid hydrazide | |
GB590040A (en) | Improvements in and relating to the synthesis of thiazolines | |
GB728368A (en) | Improvements in or relating to the production of 3-pyrazolidones | |
GB1364088A (en) | 3-substituted-thio-methyl-3-cephem-4-carboxylic acid derivatives and preparation thereof | |
GB810646A (en) | A process for the production of o.o-dialkylphosphoric or o.o-dialkylthionophosphoric acid esters of n-alkylol-lactams | |
GB801394A (en) | 1:3:4-thiadiazoles and their preparation | |
GB853441A (en) | Surface-active agents | |
GB1086038A (en) | Unsaturated sulphonic acids | |
GB948882A (en) | Process for preparing borazoles | |
GB836150A (en) | New 3-amino-6-substituted pyridazines and preparation of sulfanilamidopyridazines therefrom |